4.7 Review

The role of galectin-3 in atrial fibrillation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Autoantibodies in Atrial Fibrillation-State of the Art

Joanna Zygadlo et al.

Summary: Atrial fibrillation (AF) is the most common cardiac arrhythmia, and autoimmunity is believed to play a crucial role in its development. Autoantibodies are implicated in regulating heart rhythm and associated with AF. Identifying the autoantibody profile of different AF patient groups is essential for developing effective treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

Therapeutic implications of galectin-3 in patients with atrial fibrillation

Kwang-No Lee et al.

Summary: This study assessed the clinical implications of serum galectin-3 in patients with atrial fibrillation and found that higher galectin-3 levels were associated with increased risk of atrial fibrillation recurrence.

SCIENTIFIC REPORTS (2022)

Review Biochemistry & Molecular Biology

The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases

Grazyna Sygitowicz et al.

Summary: Galectin-3 plays a key role in chronic inflammation and is involved in various cardiovascular diseases. Its potential utility as a biomarker is discussed, along with its role in myocardial fibrosis and inflammation.

BIOMOLECULES (2022)

Article Cardiac & Cardiovascular Systems

Circulating Galectin-3 and Aldosterone for Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation

Zhong-bao Ruan et al.

Summary: The recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation (RFCA) is associated with increased levels of baseline circulating galectin-3 (Gal-3) and aldosterone (ALD). Higher preoperative Gal-3 and ALD levels are independent predictors of AF recurrence in patients undergoing RFCA.

CARDIOVASCULAR THERAPEUTICS (2022)

Article Cell Biology

Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation

Priit Pauklin et al.

Summary: Atrial fibrillation (AF) is associated with inflammatory reaction and oxidative stress, leading to fibrosis and disease progression. This study investigated the role of biomarkers in inflammation, fibrosis, and oxidative stress in AF patients. The results showed that patients with AF had increased levels of markers of inflammation and fibrosis, while there was no increase in oxidative stress marker. Myeloperoxidase (MPO) was found to be independently associated with AF occurrence and recurrence.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Cardiac & Cardiovascular Systems

The predictive value of galectin-3 levels on left atrial low voltage areas assessed by high-density mapping in patients with paroxysmal atrial fibrillation

Gokhan Aksan et al.

Summary: This study found that the levels of galectin-3 in CS serum samples were associated with the presence and extent of LVA in patients with paroxysmal AF, and it could be an independent predictor for the presence of LVA.

JOURNAL OF ARRHYTHMIA (2022)

Article Cardiac & Cardiovascular Systems

Galectin-3 is an independent predictor of postoperative atrial fibrillation and survival after elective cardiac surgery

Bernhard Richter et al.

Summary: This study aimed to evaluate the association between galectin-3 levels and POAF and mortality after cardiac surgery, and the results showed that higher levels of galectin-3 were associated with an increased risk of POAF and mortality.

HEART RHYTHM (2022)

Review Biochemistry & Molecular Biology

Extracellular Vesicles in Atrial Fibrillation-State of the Art

Grzegorz Procyk et al.

Summary: This review thoroughly summarizes current research on extracellular vesicles in atrial fibrillation, pointing out that patients with atrial fibrillation show altered levels of vesicles and their contents, but further clinical trials are needed to validate previous findings.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cardiac & Cardiovascular Systems

Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization

Qianhui Wang et al.

Summary: The plasma concentration of Gal-3 is an independent predictor of post-MI NOAF. Patients with NOAF had higher levels of age, BNP, Gal-3, and lower levels of LDL-C and e-GFR. Echocardiographic measurements also showed decreased LVEF and increased LAD in patients with NOAF.

BMC CARDIOVASCULAR DISORDERS (2022)

Article Clinical Neurology

Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge

Giuseppe Lippi et al.

Summary: Atrial fibrillation is the most frequent cardiac arrhythmia and is increasing in incidence and prevalence worldwide, especially in countries with middle socio-demographic index. The condition poses a significant economic burden and public health challenge in the future.

INTERNATIONAL JOURNAL OF STROKE (2021)

Article Medicine, General & Internal

Galectin-3 levels and the prediction of atrial high-rate episodes in patients with cardiac resynchronization therapy

Gokhan Aksan et al.

Summary: This study revealed a significant relationship between AHRE and CS galectin-3 levels, indicating that high CS galectin-3 levels can predict the development of AHRE in CRT patients.

JOURNAL OF INVESTIGATIVE MEDICINE (2021)

Article Medical Laboratory Technology

Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure

Eugene S. J. Tan et al.

Summary: In heart failure patients, higher circulating biomarker levels were independently associated with an increased risk of the primary outcome. Biomarkers such as sST2 and galectin-3 had stronger prognostic performance in the presence of atrial fibrillation, highlighting the importance of considering AF status when using these markers for risk assessment in HF.

CLINICAL CHEMISTRY (2021)

Article Medical Laboratory Technology

Multiple biomarkers measurement to estimate the duration of atrial fibrillation

Chloe Arbault-Biton et al.

Summary: This study examined the ability of several markers to identify patients with different durations of atrial fibrillation. The results showed that carbohydrate antigen-125 and growth differentiation factor-15 had high accuracy in discriminating patients with shorter atrial fibrillation duration.

ANNALS OF CLINICAL BIOCHEMISTRY (2021)

Article Cardiac & Cardiovascular Systems

Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation

Qianhui Wang et al.

Summary: This study found that elevated plasma Gal-3 concentration is significantly associated with AF progression from PAF to PsAF, indicating its potential use for risk stratification and management guidance in PAF patients.

BMC CARDIOVASCULAR DISORDERS (2021)

Review Clinical Neurology

Atrial Fibrillation and Ischemic Stroke: A Clinical Review

Ibrahim Migdady et al.

Summary: Atrial fibrillation is a significant risk factor for ischemic stroke, and stroke prevention in AF patients is typically accomplished through assessing the CHA2DS2-VASc score and selecting appropriate anticoagulants. The timing of initiation or resumption of anticoagulation for acute stroke in AF patients needs to be carefully balanced against the risk of hemorrhagic conversion.

SEMINARS IN NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

Analysis of the Correlation of Galectin-3 Concentration with the Measurements of Echocardiographic Parameters Assessing Left Atrial Remodeling and Function in Patients with Persistent Atrial Fibrillation

Pawel Walek et al.

Summary: This study showed a significant negative correlation between galectin-3 concentration and the size, systolic function, and compliance of the left atrium in patients with persistent atrial fibrillation.

BIOMOLECULES (2021)

Review Biochemistry & Molecular Biology

Galectin-3 in Cardiovascular Diseases

Valeria Blanda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cardiac & Cardiovascular Systems

Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients

Kadri Murat Gurses et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2019)

Review Biochemistry & Molecular Biology

Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications

Nicolas Clementy et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Multidisciplinary Sciences

Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation

Diana Hernandez-Romero et al.

SCIENTIFIC REPORTS (2017)

Article Cardiac & Cardiovascular Systems

Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study

Oluwaseun E. Fashanu et al.

AMERICAN HEART JOURNAL (2017)

Article Medical Laboratory Technology

Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study

Gordon A. Begg et al.

CLINICAL BIOCHEMISTRY (2017)

Letter Cardiac & Cardiovascular Systems

New onset atrial fibrillation is associated with elevated galectin-3 levels

D. Chen et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Galectin-3 in Patients With Paroxysmal and Persistent Atrial Fibrillation and Metabolic Syndrome

V. A. Ionin et al.

KARDIOLOGIYA (2016)

Article Multidisciplinary Sciences

Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation

Nicolas Clementy et al.

SCIENTIFIC REPORTS (2016)

Article Cardiac & Cardiovascular Systems

Effects of Persistent Atrial Fibrillation on Serum Galectin-3 Levels

Kadri Murat Gurses et al.

AMERICAN JOURNAL OF CARDIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling

Muhammed U. Yalcin et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Galectin 3 and incident atrial fibrillation in the community

Jennifer E. Ho et al.

AMERICAN HEART JOURNAL (2014)

Review Cardiac & Cardiovascular Systems

Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation

Brett Burstein et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)